Apoprotein A and Apoprotein B in Patients with Chronic Renal Failure Undergoing Hemodialysis and in Renal Graft Recipients
作者:
J. Rubiés-Prat,
R. Romero,
P. Chacón,
S. Masdeu,
J. Griño,
A. Caralps,
期刊:
Nephron
(Karger Available online 1983)
卷期:
Volume 35,
issue 3
页码: 171-174
ISSN:1660-8151
年代: 1983
DOI:10.1159/000183069
出版商: S. Karger AG
关键词: Apoprotein A;Apoprotein B;Cholesterol;Hemodialysis;High density lipoproteins;Hyperlipoproteinemia;Low density lipoproteins;Renal grafts;Triglycerides;Very low density lipoproteins
数据来源: Karger
摘要:
Serum concentrations of high density lipoproteins (HDL)-cholesterol, apoprotein A and apoprotein B has been studied in 13 patients with chronic renal failure treated with hemodialysis and in 12 patients with functioning renal graft. 5 patients on hemodialysis and 6 with a renal graft had hypertriglyceridemia. In the hemodialyzed patients, the increase in triglycerides was associated to a decreased concentration of serum apoprotein B. HDL-cholesterol was substantially reduced in the hemodialyzed patients without this being associated with a drop in serum apoprotein A concentration, thus suggesting that there are changes in the qualitative composition of the HDL. In renal graft recipients, the HDL-cholesterol and the apoprotein A concentration were increased. It is suggested that the risk of developing accelerated atheromatosis in patients carrying a renal graft cannot be related to changes in HDL. In patients undergoing hemodialysis, the development of atheromatosis would be related to decreased concentration and also qualitative changes in the HDL together with the increase in the VLDL and LDL.
点击下载:
PDF
(716KB)
返 回